For: | Zhang W, Ding EX, Wang Q, Zhu DQ, He J, Li YL, Wang YH. Fas ligand expression in colon cancer: A possible mechanism of tumor immune privilege. World J Gastroenterol 2005; 11(23): 3632-3635 [PMID: 15962391 DOI: 10.3748/wjg.v11.i23.3632] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i23/3632.htm |
Number | Citing Articles |
1 |
Leonie Harmse, Nurit Dahan-Farkas, Jenny-Lee Panayides, Willem van Otterlo, Clement Penny, Ferenc Gallyas. Aberrant Apoptotic Response of Colorectal Cancer Cells to Novel Nucleoside Analogues. PLOS ONE 2015; 10(9): e0138607 doi: 10.1371/journal.pone.0138607
|
2 |
Maximilian Waldner, Carl C Schimanski, Markus F Neurath. Colon cancer and the immune system: The role of tumor invading T cells. World Journal of Gastroenterology 2006; 12(45): 7233-7238 doi: 10.3748/wjg.v12.i45.7233
|
3 |
Guillaume Sarrabayrouse, Cindy Synaeve, Kevin Leveque, Gilles Favre, Anne-Françoise Tilkin-Manamé. Statins Stimulate In Vitro Membrane FasL Expression and Lymphocyte Apoptosis through RhoA/ROCK Pathway in Murine Melanoma Cells. Neoplasia 2007; 9(12): 1078 doi: 10.1593/neo.07727
|
4 |
Nurul Athirah Nasarudin, Mohd Saberi Mohamad, Zalmiyah Zakaria, Richard O. Sinnott, Fatma Al Jasmi, Noura Al Dhaheri. Identification of informative genes and sub-pathways using Improved Differential Expression Analysis for Pathways (iDEAP) for cancer classification. F1000Research 2023; 12: 1433 doi: 10.12688/f1000research.132899.1
|
5 |
Mariusz Gryko, Katarzyna Guzińska-Ustymowicz, Joanna Kiśluk, Dariusz Cepowicz, Andrzej Kemona, Bogusław Kędra. High Fas expression in gastric carcinoma cells as a factor correlating with the occurrence of metastases to regional lymph nodes. Advances in Medical Sciences 2014; 59(1): 47 doi: 10.1016/j.advms.2013.07.005
|
6 |
Julien Faget, Svenja Groeneveld, Gael Boivin, Martial Sankar, Nadine Zangger, Miguel Garcia, Nicolas Guex, Inti Zlobec, Loïc Steiner, Alessandra Piersigilli, Ioannis Xenarios, Etienne Meylan. Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer. Cell Reports 2017; 21(11): 3190 doi: 10.1016/j.celrep.2017.11.052
|
7 |
M E Peter, A Hadji, A E Murmann, S Brockway, W Putzbach, A Pattanayak, P Ceppi. The role of CD95 and CD95 ligand in cancer. Cell Death & Differentiation 2015; 22(4): 549 doi: 10.1038/cdd.2015.3
|
8 |
Magdalena Szarynska, Agata Olejniczak, Piotr Wierzbicki, Jaroslaw Kobiela, Dariusz Laski, Zbigniew Sledzinski, Krystian Adrych, Marek Guzek, Zbigniew Kmiec. FasR and FasL in colorectal cancer. International Journal of Oncology 2017; 51(3): 975 doi: 10.3892/ijo.2017.4083
|
9 |
Joseph G. Sinkovics. Cell Fusion in Health and Disease. Advances in Experimental Medicine and Biology 2011; 950: 5 doi: 10.1007/978-94-007-0782-5_2
|
10 |
Ke Xin Lin, Alexandra C. Istl, Douglas Quan, Anton Skaro, Ephraim Tang, Xiufen Zheng. PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies. Cancer Immunology, Immunotherapy 2023; 72(12): 3875 doi: 10.1007/s00262-023-03520-5
|
11 |
Haiting Mao, Qian Liu, Jiao Zhang, Hongtao Gu, Li Wang, Xianbin Zhou, Haipeng Yin, Ling Zhang, Fengxiang Xie, Guosheng Jiang. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand. International Immunopharmacology 2007; 7(13): 1714 doi: 10.1016/j.intimp.2007.09.010
|
12 |
Ming-fu Wu, Jie Yang, Tao Xiang, Yan-yan Shi, Li-jiang Liu. miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7. Journal of Huazhong University of Science and Technology [Medical Sciences] 2014; 34(2): 190 doi: 10.1007/s11596-014-1257-5
|
13 |
Chunwan Lu, John D. Klement, Dafeng Yang, Thomas Albers, Iryna O. Lebedyeva, Jennifer L. Waller, Kebin Liu. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth. Cancer Letters 2020; 476: 87 doi: 10.1016/j.canlet.2020.02.004
|
14 |
Izabela Szulc-Kielbik, Magdalena Klink. Interaction of Immune and Cancer Cells. Experientia Supplementum 2022; 113: 141 doi: 10.1007/978-3-030-91311-3_5
|
15 |
Andrea Mohr, Tianyuan Chu, Christopher T. Clarkson, Greg N. Brooke, Vladimir B. Teif, Ralf M. Zwacka. Fas-threshold signalling in MSCs promotes pancreatic cancer progression and metastasis. Cancer Letters 2021; 519: 63 doi: 10.1016/j.canlet.2021.06.017
|
16 |
|
17 |
Charalabos Pothoulakis, Monica Torre‐Rojas, Marco A. Duran‐Padilla, Jonathan Gevorkian, Odysseas Zoras, Emmanuel Chrysos, George Chalkiadakis, Stavroula Baritaki. CRHR2/Ucn2 signaling is a novel regulator of miR‐7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas‐mediated apoptosis. International Journal of Cancer 2018; 142(2): 334 doi: 10.1002/ijc.31064
|
18 |
Jianming Wu, Maureen H. Richards, Jinhai Huang, Lena Al-Harthi, Xiulong Xu, Rui Lin, Fenglong Xie, Andrew W. Gibson, Jeffrey C. Edberg, Robert P. Kimberly, Cara Gottardi. Human FasL Gene Is a Target of β-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions. PLoS ONE 2011; 6(10): e26143 doi: 10.1371/journal.pone.0026143
|
19 |
Anna Pryczynicz, Katarzyna Guzińska-Ustymowicz, Andrzej Kemona. Fas/FasL expression in colorectal cancer. An immunohistochemical study.. Folia Histochemica et Cytobiologica 2010; 48(3) doi: 10.2478/v10042-010-0058-3
|
20 |
Larissa Belov, Jerry Zhou, Richard I. Christopherson. Cell Surface Markers in Colorectal Cancer Prognosis. International Journal of Molecular Sciences 2010; 12(1): 78 doi: 10.3390/ijms12010078
|
21 |
Magdalena Klink, Zofia Sulowska. Interaction of Immune and Cancer Cells. 2014; : 123 doi: 10.1007/978-3-7091-1300-4_7
|